ZENITH DRUGS LIMITED Share Price

ZENITH DRUGS LIMITED Share Price

NSE: ZENITHDRUG
|
Pharmaceuticals
|
S Cap
₹ 40.85
+₹0.85 (2.13%)
1D
Last updated 03 Sep, 2026, 11:42 IST

ZENITH DRUGS LIMITED Share Price Today

As of 3 Sep 2026, ZENITH DRUGS LIMITED share price is ₹40.85. The stock opened at ₹40.05, compared to its previous close of ₹40.00. During today's trading session, ZENITH DRUGS LIMITED share price moved in the range of ₹40.00 to ₹41.40, with an average price of ₹40.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹33.30 and a high of ₹73.45. On the performance front, ZENITH DRUGS LIMITED share price has declined by 18.37% over the last six months and is down 43.54% on a year-on-year basis.

₹40.00
2.13% up today
₹41.40
1D LOW
1D HIGH

ZENITH DRUGS LIMITED Returns Calculator

Circuit
L
H
₹32.00
₹48.00
52-week
L
H
₹33.30
₹73.45

About ZENITH DRUGS LIMITED

ZENITH DRUGS LIMITED Share Price
ISIN
INE0QWN01013
Sector Market Cap
₹ 107.52 Cr

Zenith Drugs Ltd is an India-based pharmaceutical company. The Company is mainly engaged in the business of manufacturing and trading of medicine. The Company offers a range of formulations in various forms, such as ORS powder, liquid oral, ointments, creams, gels and liquid externals, capsules, tablets. Its liquid oral products include Aceclofenac & Paracetamol Suspension; Albendazole Oral Suspension BP 25 mg/ml; Ambroxol Hydrochloride & Levocetirizine Dihydrochloride Syrup; Bromhexine Hydrochloride Syrup 4mg/5ml; Cetirizine Dihydrochloride and AmbroxolHydrochloride Syrup; Cetirizine Dihydrochloride and AmbroxolHydrochloride Syrup; Chlorphenamine, Ammonium Chloride and Sodium Citrate Syrup; Chlorpheniramine Maleate Oral Solution USP 2 mg / 5 ml, and others. Its ointment products include Cetrimide Cream BP 0.5% w/w, Chloroxylenol Cream 0.8% w/w, Ciprofloxacin Cream 0.5% w/w, Ciprofloxacin with Fluocinolone & Clotrimazole Cream and others.

ZENITH DRUGS LIMITED Financial Highlights

  • Revenue: ZENITH DRUGS LIMITED reported revenue of ₹133.74 crore in FY24 vs ₹115.76 crore in FY23. It showed an increase of 15.53% on a yearly basis.
  • Operating Profit: ZENITH DRUGS LIMITED reported an operating profit of ₹14.74 crore in FY24 vs ₹6.66 crore in FY23. It showed an increase of 121.32% on a year-on-year basis.
  • Net Profit: ZENITH DRUGS LIMITED reported a net profit of ₹9.65 crore in FY24 vs ₹4.88 crore in FY23. It showed an increase of 97.75% on a yearly basis.
Know more
Promoters
69.98%
FII
0.00%
Other DII
0.00%
Retail and other
30.02%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20240.42%
Mar 20250.06%
Sep 20250.00%
Mar 20260.00%
Mkt Cap Cr
107.52
P/E
11.22
P/B
1.73
ROE
24.13%
D/E
0.74
ROCE
25.16%
Div. Yield
0.00%
EPS(TTM)
2.30
Turnover
1.80
EV/EBITDA
6.95
Net Margin
0.00%
Op. Margin
0.00%
ROA
11.03%
Quick Ratio
0.00
Curr. Ratio
2.24
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Zenith Drugs has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Zenith Drugs appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Zenith Drugs earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,833.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,163.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,431.0017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%396.980.04%0.4449.37
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

ZENITH DRUGS LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022
Revenue₹131.62₹114.52₹91.66
Other Income₹2.12₹1.24₹1.01
Total Revenue₹133.74₹115.76₹92.67
Total Expenses₹119.00₹109.10₹88.26
Profit Before Tax₹13.44₹6.66₹4.41
Tax₹3.80₹1.78₹1.28
Profit After Tax₹9.65₹4.88₹3.13
EPS - Basic₹5.63₹122.02₹78.22
EPS - Diluted₹5.63₹122.02₹78.22

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022
Profit before tax₹13.44₹6.66₹4.41
Income before WC changes₹17.74₹10.27₹7.87
Change in Assets-₹20.88-₹30.50-₹16.97
Change in Liabilities-₹5.84₹17.29₹15.57
Change in WC-₹26.72-₹13.22-₹1.40
Cash flow from Operations-₹13.01-₹4.77₹5.15
Cash flow from Investing₹26.00-₹0.27-₹5.24
Cash flow from Financing-₹4.47₹4.99₹1.24
Total Cash Flow₹8.52-₹0.05₹1.15
Cash (Start of the year)₹0.28₹0.33₹1.85
Cash (End of the year)₹8.80₹0.28₹3.00

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022
Non-Current Assets₹21.71₹14.00₹15.05
Current Assets₹113.33₹83.92₹53.53
Total Assets₹135.04₹97.92₹68.58
Current Liabilities₹64.15₹71.65₹46.58
Net Current Asset₹49.18₹12.27₹6.95
Non-Current Liabilities₹8.56₹8.53₹9.90
Equity Capital₹62.33₹17.74₹12.11
Total Equity & Liabilities₹135.04₹97.92₹68.58

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹133.32₹131.62₹114.52₹91.66
Other Income₹2.61₹2.12₹1.24₹0.95
Total Revenue₹135.93₹133.74₹115.76₹92.60
Total Expenses₹126.42₹118.89₹109.10₹88.20
Profit Before Tax₹9.26₹13.29₹6.66₹4.40
Tax₹2.10₹3.76₹1.78₹1.19
Profit After Tax₹7.16₹9.54₹4.88₹3.21
EPS - Basic₹4.18₹5.56₹122.03₹80.32
EPS - Diluted₹4.18₹5.56₹122.03₹80.32

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹9.51₹13.29₹6.66₹4.40
Income before WC changes₹15.89₹17.59₹10.29₹7.87
Change in Assets-₹11.11-₹20.56-₹30.31-₹16.90
Change in Liabilities-₹4.49-₹5.88₹17.58₹15.18
Change in WC-₹15.60-₹26.44-₹12.73-₹1.72
Cash flow from Operations-₹5.47-₹15.84-₹4.27₹4.91
Cash flow from Investing-₹31.41-₹5.33-₹2.05-₹3.04
Cash flow from Financing₹28.39₹29.72₹6.30-₹0.83
Total Cash Flow-₹8.48₹8.55-₹0.01₹1.04
Cash (Start of the year)₹8.74₹0.20₹0.21₹1.85
Cash (End of the year)₹0.26₹8.74₹0.20₹2.89

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹46.30₹21.34₹13.14₹12.40
Current Assets₹115.18₹112.84₹84.08₹53.79
Total Assets₹161.48₹134.17₹97.22₹66.18
Current Liabilities₹79.30₹64.10₹71.65₹45.53
Net Current Asset₹35.87₹48.73₹12.43₹8.26
Non-Current Liabilities₹12.80₹7.85₹7.84₹7.81
Equity Capital₹69.38₹62.22₹17.73₹12.85
Total Equity & Liabilities₹161.48₹134.17₹97.22₹66.18
* All values are in INR Crore
Qty
Bid
800
40
2400
39.8
800
39.7
800
39.65
800
39.4
Ask
Qty
41.35
800
41.45
800
41.9
800
41.95
800
42
800
Bid Total: 5600
Ask Total: 4000
Buy orders: 58%
Sell orders: 42%
Bearish
1
Neutral
3
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
39.88
Neutral
ATR (14)
1.93
Neutral
STOCH(9,6)
0
Bullish
STOCH RSI (14)
6.9
Bullish
ADX(9)
19.59
Bullish
UO(9)
39.13
Neutral
ROC(12)
-10.41
Bearish
WillR(14)
-100
Bullish
Period
Simple value
Exponential vaue
5D
41.81
41.4
10D
41.98
42.02
20D
42.88
43.14
50D
46.34
44.54
100D
44.19
44.99
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L
Compare against other stocks
ZENITH DRUGS LIMITED Share Price
ZENITH DRUGS LIMITED
Pharmaceuticals
Add Stock
Add Another

ZENITH DRUGS LIMITED Share Price FAQs